Tampering in some U.S. bottles of weight-loss drug Alli: Glaxo

(Reuters) – Some bottles of Alli, GlaxoSmithKline Plc's weight-loss drug sold over the counter in the United States, have been tampered with, and the Food and Drug Administration was investigating, the company said on Wednesday. Consumers have reported that about 20 bottles bought in stores in seven mostly Southern states contained products other than the drug, GlaxoSmithKline said. The bottles could be unlabeled and the lot numbers might not match the numbers on the carton, GlaxoSmithKline said. Glaxo spokeswoman Deborah Bolding said that so far there have been no reports of serious illness related to the products.